These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 6489160)
1. Theoretical and quantum prediction of toxic effects. Kaufman JJ; Koski WS; Hariharan PC; Garmer DM; Crawford J; Chan-Lizardo L; Sipos EP Drug Metab Rev; 1984; 15(3):527-56. PubMed ID: 6489160 [No Abstract] [Full Text] [Related]
2. Design and structure-activity relationships of antidotes to organophosphorus anticholinesterase agents. Gray AP Drug Metab Rev; 1984; 15(3):557-89. PubMed ID: 6386410 [No Abstract] [Full Text] [Related]
3. A review of organophosphorus ester-induced delayed neurotoxicity. Barrett DS; Oehme FW; Kruckenberg SM Vet Hum Toxicol; 1985 Feb; 27(1):22-37. PubMed ID: 3883641 [No Abstract] [Full Text] [Related]
4. Effects of chemical reactivity of the toxicity of phosphorus fluoridates. White WE SAR QSAR Environ Res; 1999; 10(2-3):207-13. PubMed ID: 10491850 [TBL] [Abstract][Full Text] [Related]
5. [Finding cholinesterase in endotheliocytes: cholinesterase inhibition by organophosphorus compounds leads to endotheliocyte deformation]. Prozorovskiĭ VB; Skopichev VG Eksp Klin Farmakol; 2005; 68(3):64-7. PubMed ID: 16047685 [TBL] [Abstract][Full Text] [Related]
6. Bicyclic phosphorus esters: high toxicity without cholinesterase inhibition. Bellet EM; Casida JE Science; 1973 Dec; 182(4117):1135-6. PubMed ID: 4356280 [TBL] [Abstract][Full Text] [Related]
8. The biological importance of organophosphorus compounds containing a carbon-phosphorus bond. Inch TD Ciba Found Symp; 1977 Sep 13-15; (57):135-53. PubMed ID: 357117 [TBL] [Abstract][Full Text] [Related]
9. QSTR of the toxicity of some organophosphorus compounds by using the quantum chemical and topological descriptors. Senior SA; Madbouly MD; El massry AM Chemosphere; 2011 Sep; 85(1):7-12. PubMed ID: 21757222 [TBL] [Abstract][Full Text] [Related]
10. Organophosphorus compounds; the past and the future. Nelson DL; Crawford CR Clin Toxicol; 1972; 5(2):223-30. PubMed ID: 4559018 [No Abstract] [Full Text] [Related]
11. Roles of dopamine and GABA in neurotoxicity of organophosphorus cholinesterase inhibitors. Ho IK; Fernando JC; Sivam SP; Hoskins B Proc West Pharmacol Soc; 1984; 27():177-80. PubMed ID: 6494152 [No Abstract] [Full Text] [Related]
12. New organophosphorus compounds: cholinesterases inhibition, cytotoxicity and lethal dose. Sega EM; Reis AK; Olivato PR; Rodrigues A; de Carvalho JE; Castilho RF; Rittner R; Höehr NF Clin Chim Acta; 2008 Mar; 389(1-2):177-80. PubMed ID: 18155164 [No Abstract] [Full Text] [Related]
13. Organophosphorus compounds. I. Toxicity in domestic animals. Abdelsalam EB Vet Res Commun; 1987; 11(3):211-9. PubMed ID: 3307131 [TBL] [Abstract][Full Text] [Related]
14. Mechanistic insight into acetylcholinesterase inhibition and acute toxicity of organophosphorus compounds: a molecular modeling study. Guo JX; Wu JJ; Wright JB; Lushington GH Chem Res Toxicol; 2006 Feb; 19(2):209-16. PubMed ID: 16485896 [TBL] [Abstract][Full Text] [Related]
15. Effects of the irreversible acetylcholinesterase inhibitor soman on match-to-sample behavior of the juvenile baboon. Geller I; Hartmann RJ; Leal BZ; Haines RJ; Gause EM Proc West Pharmacol Soc; 1984; 27():217-21. PubMed ID: 6494157 [No Abstract] [Full Text] [Related]
17. Molecular determinants for drug-receptor interactions. 1. Solid-state structure and conformation of the novel nootropic agent 2-pyrrolidone-N-acetamide: X-ray and theoretical SCF-MO studies. Bandoli G; Clemente DA; Grassi A; Pappalardo GC Mol Pharmacol; 1981 Nov; 20(3):558-64. PubMed ID: 7329398 [No Abstract] [Full Text] [Related]
18. The toxicity of organophosphorus compounds to mammals. DuBois KP Bull World Health Organ; 1971; 44(1-3):233-40. PubMed ID: 4328820 [TBL] [Abstract][Full Text] [Related]